Keyphrases
Chromothripsis
95%
Structural Variants
73%
Structural Variation
54%
In Cancer
37%
Nanopore Sequencing
35%
Mutation Burden
32%
Ovarian Cancer
32%
Multiplexing
32%
Mate-pair Sequencing
31%
Fusion Gene
30%
Congenital Abnormalities
29%
Genome Rearrangement
27%
Colorectal Cancer
27%
Human Genome
26%
Structural Change
24%
DNA Double-strand Breaks
24%
Therapy Resistance
24%
Congenital Disorders
24%
Duplication
22%
Protein-coding Genes
21%
Nave
21%
Germ Cells
21%
Chromosomal Aberrations
21%
Long-read Sequencing
21%
DNA Sequencing
21%
Genomic Structural Variation
20%
Micronucleus
20%
Tumor Heterogeneity
20%
Structural Rearrangement
20%
Copy number Variation
19%
Gene Detection
19%
BRAF Gene Fusion
19%
Metastatic Colorectal Cancer (mCRC)
19%
Oncogenic Fusion
19%
Tumor Samples
19%
Cell Division
19%
Metastasis
18%
Chromosomal Rearrangements
18%
Intellectual Disability
18%
Metagenomic Next-generation Sequencing (mNGS)
17%
Induced Pluripotent Stem Cells (iPSCs)
16%
Pluripotent Cells
16%
Primary Colon Cancer
16%
Transcriptomic Plasticity
16%
Balanced Chromosomal Abnormalities
16%
Smc5
16%
Diversification Pattern
16%
Cell Generation
16%
Severe Lung Disease
16%
Dehydrogenase Deficiency
16%
Biochemistry, Genetics and Molecular Biology
Chromothripsis
100%
Genomics
91%
Gene Fusion
33%
Next Generation Sequencing
30%
Chromosomal Rearrangement
29%
Oncogene
27%
Human Genome
26%
Fusion Gene
25%
Germline
24%
Germ Cell
24%
Double Stranded DNA Break
24%
Intellectual Disability
24%
Microarrays
24%
Indel
24%
Structural Genomics
24%
Chromosomal Aberration
21%
Genome Sequencing
21%
Progeny
20%
Karyotype
19%
Exome
18%
Cancer Cell
17%
Induced Pluripotent Stem Cell
16%
Copy-Number Variation
16%
CRISPR/Cas9
16%
Colon
16%
Metabolic Pathway
16%
Solution and Solubility
16%
Transcriptomics
16%
Lactate Dehydrogenase
16%
Cytogenetics
16%
Epidermal Growth Factor Receptor
16%
BRCA1
16%
Genotyping
16%
Chromosome Breakage
16%
Circulating Tumor DNA
16%
BRAF (Gene)
16%
Chromosomal Abnormalities
16%
Gene Expression
15%
Dynamics
14%
Whole Genome Sequencing
14%
Karyotyping
14%
Retrotransposon
12%
Lamin
10%
Mutation Rate
10%
Genetic Variation
10%
Tumor Gene
10%
SNP Array
9%
DNA Damage
9%
Zebra Fish
8%
Gene Function
8%
Medicine and Dentistry
Neoplasm
51%
Ovarian Cancer
32%
Malignant Neoplasm
31%
Organoid
25%
Therapy Resistance
20%
Colorectal Carcinoma
20%
Chemotherapy
18%
Gene Fusion
17%
Karyotype
16%
Epidermal Growth Factor Receptor
16%
Targeted Therapy
16%
BRAF (Gene)
16%
Gene Expression
16%
Copy Number Variation
16%
Breast Cancer
16%
Respiratory Failure
16%
Transcriptomics
16%
Congenital Heart Defect
16%
BRCA1
16%
Xenograft
16%
Tumour Heterogeneity
10%
Chylothorax
8%
Receptor Family
8%
Fusion Gene
8%
Serositis
8%
Neurologic Examination
8%
Chromosome 19
8%
Edema
8%
Sepsis
8%
Omentum
8%
Fluorescence in Situ Hybridization
8%
Tumor Gene
8%
Arm
8%
Gene Deletion
8%
SNP Array
8%
Hematopoietic Cell
8%
Germ Cell
8%
Recurrent Disease
7%
Personalized Medicine
6%
Cell Division
5%
